China Pharma Holdings (CPHI) Total Debt (QoQ) (2011 - 2026)
China Pharma Holdings (CPHI) Total Debt (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.16% |
| Dec 31, 2025 | -26.62% |
| Sep 30, 2025 | -28.29% |
| Jun 30, 2025 | 16.90% |
| Mar 31, 2025 | -8.00% |
| Dec 31, 2024 | 2.73% |
| Sep 30, 2024 | 1.70% |
| Jun 30, 2024 | -0.45% |
| Mar 31, 2024 | -4.22% |
| Dec 31, 2023 | 5.65% |
| Sep 30, 2023 | -15.07% |
| Jun 30, 2023 | -4.90% |
| Mar 31, 2023 | 22.22% |
| Dec 31, 2022 | -46.90% |
| Sep 30, 2022 | 42.16% |
| Jun 30, 2022 | -24.81% |
| Mar 31, 2022 | -21.93% |
| Dec 31, 2021 | 244.26% |
| Sep 30, 2021 | -35.80% |
| Jun 30, 2021 | -16.44% |